Bernard J Fanget

Title: The Innovations of Bernard J Fanget

Introduction

Bernard J Fanget is a notable inventor based in L'Arbresle, France. He has made significant contributions to the field of vaccine production, particularly in the development of a process for large-scale production of poliomyelitis vaccine. His innovative approach has the potential to enhance vaccine availability and efficacy.

Latest Patents

Bernard J Fanget holds a patent for a process that involves several critical steps for the large-scale production of a poliomyelitis vaccine. This process includes the multiplication of a cell strain in a liquid nutritive medium on microcarriers, followed by successive passages into biogenerators of increasing volumes. The final biogenerator has a capacity of at least 150 liters, and the medium used contains serum. The process is carefully controlled, with stirring rates not exceeding 40 rpm. After the final passage, the medium is replaced with a serum-free one, and the biogenerator is inoculated with the virus for further development. The resulting liquid suspension undergoes filtration, concentration, and chromatography before being inactivated and prepared for individual dosages.

Career Highlights

Fanget's career is marked by his dedication to advancing vaccine production techniques. His work at the company, Société Anonyme Dite: Institut Merueux, has positioned him as a key figure in the field of immunology. His innovative methods have the potential to significantly impact public health by improving vaccine production efficiency.

Collaborations

Bernard J Fanget has collaborated with fellow inventor Bernard J Montagnon, contributing to the advancement of vaccine technologies. Their partnership exemplifies the importance of teamwork in the field of scientific research and innovation.

Conclusion

Bernard J Fanget's contributions to vaccine production highlight the importance of innovation in public health. His patented process for the large-scale production of poliomyelitis vaccine represents a significant advancement in the field. Through his work, Fanget continues to pave the way for improved vaccine accessibility and effectiveness.